Pasi Koskimies

No ORCID on file · 6 papers in corpus · active 2006-2022

Study types

  • article 3
  • other 3

Condition tags

  • endometriosis 4
  • adenomyosis 1
article 2022
International journal of molecular sciences ·doi:10.3390/ijms23094815

Hydroxysteroid (17beta) dehydrogenase type 1 (HSD17B1) is an enzyme that converts estrone to estradiol, while adenomyosis is an estrogen-dependent disease with poorly understood pathophysiology. In the present study, we show that mice unive…

other 2018
Journal of enzyme inhibition and medicinal chemistry ·doi:10.1080/14756366.2018.1452919

A comprehensive set of 3-phenylcoumarin analogues with polar substituents was synthesised for blocking oestradiol synthesis by 17-β-hydroxysteroid dehydrogenase 1 (HSD1) in the latter part of the sulphatase pathway. Five analogues produced …

article 2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-2851

CONTEXT: Endometriosis affects 10% of the women before menopause and has important personal, professional, and societal economic burdens. Because current medical treatments are aimed at reducing the symptoms only, novel therapeutic targets …

article 2010
·doi:10.2353/ajpath.2010.090325
other 2009
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2008.10.022

Lowering local estradiol concentration by inhibition of the estradiol-synthesizing enzyme 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) has been proposed as a promising new therapeutic option to treat estrogen-dependent diseases …

other 2006
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2005.11.044

The estradiol-synthesizing enzyme 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) is mainly responsible for the conversion of estrone (E1) to the potent estrogen estradiol (E2). It is a key player to control tissue levels of E2 and …